A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban

NCT02213029 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Embryo Transfer

Interventions

DRUG: Epelsiban
DRUG: Placebo
DRUG: Oxytocin
DRUG: Ortho-Cylcen (21)® tablet

Sponsor

GlaxoSmithKline